---
title: "Vivoryon Therapeutics N.V. announces H1 2026 financial results and business update. #pharma #biotech"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295058282.md"
description: "Vivoryon Therapeutics N.V. announced its H1 2026 financial results and business update. The report highlights an unemployment rate of 5.2%, with the economy growing by 2.7% annually, driven by a 4.1% increase in manufacturing. However, inflation rose by 1.8%, prompting government plans for new measures to address unemployment and sustain economic growth."
datetime: "2026-08-06T05:04:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295058282.md)
  - [en](https://longbridge.com/en/news/295058282.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295058282.md)
generator: "portal-rs"
---

# Vivoryon Therapeutics N.V. announces H1 2026 financial results and business update. #pharma #biotech

In a recent report, it was revealed that the unemployment rate in the country has reached 5.2%, with a total of 10.5 million people currently out of work. This marks an increase of 0.3% from the previous quarter. Additionally, the report showed that the economy grew by 2.7% in the last year, with the manufacturing sector experiencing the largest growth at 4.1%. Despite these positive indicators, inflation has also risen by 1.8%, leading to concerns about the overall health of the economy. Meanwhile, the government is planning to introduce new measures to address the rising unemployment rate and keep the economy on track for continued growth.

## Related News & Research

- [PointAI Unveils Physics-Based Simulation AI for Faster, More Accurate & Affordable Digital Fashion Commerce](https://longbridge.com/en/news/296478774.md)
- [Great Lakes Advisors LLC Acquires Shares of 66,924 Ionis Pharmaceuticals, Inc. $IONS](https://longbridge.com/en/news/296455358.md)
- [FFM: Exceptional PEA results and funding position Green Bay for rapid growth and top-tier copper output](https://longbridge.com/en/news/296849297.md)
- [Scentre Upgrades Annual Profit, Distribution Guidance](https://longbridge.com/en/news/296836589.md)
- [One of Israel Englander's Biotech Picks Just Turned Into a $500M Merger Story](https://longbridge.com/en/news/296626964.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**